What Happened to DocuSign, Inc. Stock?

DocuSign, Inc. (NASDAQ: DOCU) went public on April 27, 2018, with its shares priced at $29.00, raising approximately $629 million. The company, a pioneer in electronic signature technology, quickly gained traction, but its growth trajectory accelerated dramatically with the onset of the COVID-19 pandemic in early 2020. As businesses worldwide shifted to remote work, the demand for digital agreement solutions, particularly e-signatures, skyrocketed. DocuSign's stock became a 'pandemic darling,' soaring from approximately $74 per share at the start of 2020 to an all-time high of around $310-$314.76 in late 2021.

The post-pandemic period brought a significant correction for DocuSign's stock. As global economies reopened and the initial surge in digital transformation normalized, investor sentiment shifted away from high-growth, pandemic-benefiting tech stocks. This led to a sharp decline in DocuSign's share price, with the stock falling more than 80% from its peak by early 2026. Concerns about growth deceleration and increased competition contributed to this downturn. In June 2022, CEO Dan Springer stepped down, and Mary Agnes 'Maggie' Wilderotter was appointed interim CEO, followed by Allan Thygesen taking the helm in October 2022, signaling a new strategic direction for the company.

Under Allan Thygesen's leadership, DocuSign has focused on evolving beyond its core e-signature product to become a comprehensive Intelligent Agreement Management (IAM) platform. This strategic pivot, heavily leveraging artificial intelligence (AI), aims to automate and optimize the entire agreement lifecycle, from drafting and negotiation to execution and management. The IAM platform, which launched in 2025, has shown promising early adoption, representing 10.8% of total Annual Recurring Revenue (ARR) by January 2026 and growing to 12.6% by April 2026. DocuSign has integrated AI-powered features like AI-Assisted Agreement Type Detection and AI-Assisted Review to enhance efficiency and reduce manual effort.

As of August 2026, DocuSign's financial performance reflects a more mature, yet stable growth phase. For fiscal year 2026 (ended January 31, 2026), the company reported total revenue of $3.22 billion, an 8.16% increase year-over-year. While GAAP net income decreased significantly to $309.09 million in FY26, largely due to normalization in income tax provisions, the company achieved record highs for operating margin and free cash flow, surpassing $1 billion in free cash flow for the year. DocuSign also announced a $2.0 billion increase to its share repurchase program in March 2026, demonstrating confidence in its financial health. In Q1 fiscal year 2027 (ended April 30, 2026), revenue grew 9% year-over-year to $830.2 million, with non-GAAP diluted EPS reaching $1.09, exceeding analyst expectations.

The stock price has shown some recovery in 2026 after hitting a 52-week low of $40.16 in February. As of August 4, 2026, DocuSign's stock was trading around $57.54, with a market capitalization of approximately $10.99 billion. Analysts maintain a 'Hold' consensus, with a median 12-month price target of $55. The company continues to invest in its IAM platform, expanding its capabilities for various enterprise workflows like HR and procurement, and leveraging its vast dataset of over 200 million private consented agreements for AI development. DocuSign aims to solidify its position as a leader in agreement automation, moving beyond just e-signatures to drive broader business outcomes through AI and workflow integration.